The above studies indicate that the resistance mechanisms in KRAS-mutant CRC are dynamic and multifaceted processes, involving feedback activation, acquired genetic changes, and reprogramming of core cellular processes such as protein homeostasis and apoptosis. Here, KRAS is linked to colorectal carcinoma.